Clinical presentation and course of acute hepatitis C infection in HIV-infected patients

Article Abstract:

A study is conducted to examine the clinical presentation and the outcomes of acute hepatitis C virus in HIV-infected people by using the antiretroviral therapy. The results show that the unexplained transminase elevations in HIV-infected men should lead to an evaluation of acute HIV infection, which can be treated effectively and accurately by its prompt recognition.

Care and treatment, Risk factors, Diseases, Hepatitis C

---

Association between hepatitis C virus coinfection and regional adipose tissue volume in HIV-infected men and women

Article Abstract:

The association between hepatitis C virus (HCV) and adipose tissue volume in HIV-infected men and women is examined. The results have shown that HIV/HCV coinfection is not associated with less subcutaneous adipose tissue (SAT) in men and women, but HCV infection seems to mitigate the loss of leg fat seen in HIV-infected men on stavudine.

Complications and side effects, Adipose tissues, Adipose tissue, Comorbidity, Hepatitis C virus, Clinical report

---

CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy

Article Abstract:

HIV patients have greater than normal amounts of the CCR5 receptor and fewer than normal CXCR4 receptors and this is due to upregulation or downregulation within the subsets rather than a shift in subset proportions. Highly active antiretroviral therapy (HAART) can reduce CCR5 levels but has no effect on CXCR4 levels.

Research, Physiological aspects, HIV (Viruses), HIV, Cell receptors, Virus receptors, Anti-HIV agents

Similar abstracts:

• Abstracts: Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites
• Abstracts: Epoetin alfa for treatment of anemia in HIV-infected patients: past, present, and future. Introduction
• Abstracts: Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker
• Abstracts: Hepatitis E virus and chronic hepatitis in organ-transplant recipients
• Abstracts: Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP trial

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.